human MDA468 cells |
Proliferation assay |
|
3 days |
|
Antiproliferative activity against human MDA468 cells after 3 days by MTS assay, IC50=8 nM |
21438579 |
human LNCAP cells |
Proliferation assay |
|
3 days |
|
Antiproliferative activity against human LNCAP cells after 3 days by MTS assay, IC50=0.5 nM |
21438579 |
A498 |
Cytotoxicity assay |
|
72 hrs |
|
Cytotoxicity against human A498 cells after 72 hrs by MTT assay, IC50 = 0.35 μM. |
25124114 |
A498 |
Cytotoxicity assay |
|
6 days |
|
Cytotoxicity against human A498 cells assessed as inhibition of cell viability after 6 days by MTT assay, IC50 = 0.5 μM. |
23360104 |
HEK293 |
Function assay |
|
|
|
Inhibition of FKBP12-independent human recombinant mTOR expressed in HEK293 cells using His6-S6K1 as a substrate by DELFIA assay, IC50 = 1.76 μM. |
21438579 |
HSC-4 |
Growth inhibition assay |
|
|
|
Inhibition of human HSC-4 cell growth in a cell viability assay, IC50 = 0.0001134 μM. |
SANGER |
L-363 |
Growth inhibition assay |
|
|
|
Inhibition of human L-363 cell growth in a cell viability assay, IC50 = 0.000242 μM. |
SANGER |
Ramos-2G6-4C10 |
Growth inhibition assay |
|
|
|
Inhibition of human Ramos-2G6-4C10 cell growth in a cell viability assay, IC50 = 0.0003419 μM. |
SANGER |
SBC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SBC-1 cell growth in a cell viability assay, IC50 = 0.0004442 μM. |
SANGER |
MHH-PREB-1 |
Growth inhibition assay |
|
|
|
Inhibition of human MHH-PREB-1 cell growth in a cell viability assay, IC50 = 0.0004955 μM. |
SANGER |
HH |
Growth inhibition assay |
|
|
|
Inhibition of human HH cell growth in a cell viability assay, IC50 = 0.0006644 μM. |
SANGER |
TYK-nu |
Growth inhibition assay |
|
|
|
Inhibition of human TYK-nu cell growth in a cell viability assay, IC50 = 0.0007781 μM. |
SANGER |
H4 |
Growth inhibition assay |
|
|
|
Inhibition of human H4 cell growth in a cell viability assay, IC50 = 0.001073 μM. |
SANGER |
K5 |
Growth inhibition assay |
|
|
|
Inhibition of human K5 cell growth in a cell viability assay, IC50 = 0.001331 μM. |
SANGER |
PA-1 |
Growth inhibition assay |
|
|
|
Inhibition of human PA-1 cell growth in a cell viability assay, IC50 = 0.00147 μM. |
SANGER |
SK-NEP-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-NEP-1 cell growth in a cell viability assay, IC50 = 0.00149 μM. |
SANGER |
697 |
Growth inhibition assay |
|
|
|
Inhibition of human 697 cell growth in a cell viability assay, IC50 = 0.0017 μM. |
SANGER |
CTB-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CTB-1 cell growth in a cell viability assay, IC50 = 0.002934 μM. |
SANGER |
DB |
Growth inhibition assay |
|
|
|
Inhibition of human DB cell growth in a cell viability assay, IC50 = 0.003123 μM. |
SANGER |
MLMA |
Growth inhibition assay |
|
|
|
Inhibition of human MLMA cell growth in a cell viability assay, IC50 = 0.003313 μM. |
SANGER |
GAMG |
Growth inhibition assay |
|
|
|
Inhibition of human GAMG cell growth in a cell viability assay, IC50 = 0.003823 μM. |
SANGER |
JVM-3 |
Growth inhibition assay |
|
|
|
Inhibition of human JVM-3 cell growth in a cell viability assay, IC50 = 0.003952 μM. |
SANGER |
LAMA-84 |
Growth inhibition assay |
|
|
|
Inhibition of human LAMA-84 cell growth in a cell viability assay, IC50 = 0.004033 μM. |
SANGER |
RPMI-8226 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-8226 cell growth in a cell viability assay, IC50 = 0.004148 μM. |
SANGER |
MOLT-4 |
Growth inhibition assay |
|
|
|
Inhibition of human MOLT-4 cell growth in a cell viability assay, IC50 = 0.004306 μM. |
SANGER |
CAMA-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAMA-1 cell growth in a cell viability assay, IC50 = 0.004771 μM. |
SANGER |
NCI-SNU-1 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-SNU-1 cell growth in a cell viability assay, IC50 = 0.004806 μM. |
SANGER |
SW780 |
Growth inhibition assay |
|
|
|
Inhibition of human SW780 cell growth in a cell viability assay, IC50 = 0.004827 μM. |
SANGER |
H9 |
Growth inhibition assay |
|
|
|
Inhibition of human H9 cell growth in a cell viability assay, IC50 = 0.00488 μM. |
SANGER |
BE-13 |
Growth inhibition assay |
|
|
|
Inhibition of human BE-13 cell growth in a cell viability assay, IC50 = 0.004907 μM. |
SANGER |
ES8 |
Growth inhibition assay |
|
|
|
Inhibition of human ES8 cell growth in a cell viability assay, IC50 = 0.005268 μM. |
SANGER |
DEL |
Growth inhibition assay |
|
|
|
Inhibition of human DEL cell growth in a cell viability assay, IC50 = 0.00546 μM. |
SANGER |
QIMR-WIL |
Growth inhibition assay |
|
|
|
Inhibition of human QIMR-WIL cell growth in a cell viability assay, IC50 = 0.005708 μM. |
SANGER |
CGTH-W-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CGTH-W-1 cell growth in a cell viability assay, IC50 = 0.005755 μM. |
SANGER |
CHL-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CHL-1 cell growth in a cell viability assay, IC50 = 0.005856 μM. |
SANGER |
A2780 |
Growth inhibition assay |
|
|
|
Inhibition of human A2780 cell growth in a cell viability assay, IC50 = 0.005882 μM. |
SANGER |
VA-ES-BJ |
Growth inhibition assay |
|
|
|
Inhibition of human VA-ES-BJ cell growth in a cell viability assay, IC50 = 0.005896 μM. |
SANGER |
BB65-RCC |
Growth inhibition assay |
|
|
|
Inhibition of human BB65-RCC cell growth in a cell viability assay, IC50 = 0.007004 μM. |
SANGER |
D-566MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-566MG cell growth in a cell viability assay, IC50 = 0.007157 μM. |
SANGER |
HO-1-N-1 |
Growth inhibition assay |
|
|
|
Inhibition of human HO-1-N-1 cell growth in a cell viability assay, IC50 = 0.008201 μM. |
SANGER |
RS4-11 |
Growth inhibition assay |
|
|
|
Inhibition of human RS4-11 cell growth in a cell viability assay, IC50 = 0.00845 μM. |
SANGER |
PC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human PC-3 cell growth in a cell viability assay, IC50 = 0.009142 μM. |
SANGER |
NB69 |
Growth inhibition assay |
|
|
|
Inhibition of human NB69 cell growth in a cell viability assay, IC50 = 0.009464 μM. |
SANGER |
HGC-27 |
Growth inhibition assay |
|
|
|
Inhibition of human HGC-27 cell growth in a cell viability assay, IC50 = 0.009598 μM. |
SANGER |
NCI-H720 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H720 cell growth in a cell viability assay, IC50 = 0.009617 μM. |
SANGER |
NCI-H292 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H292 cell growth in a cell viability assay, IC50 = 0.009837 μM. |
SANGER |
A3-KAW |
Growth inhibition assay |
|
|
|
Inhibition of human A3-KAW cell growth in a cell viability assay, IC50 = 0.01043 μM. |
SANGER |
DU-4475 |
Growth inhibition assay |
|
|
|
Inhibition of human DU-4475 cell growth in a cell viability assay, IC50 = 0.01173 μM. |
SANGER |
HuH-7 |
Growth inhibition assay |
|
|
|
Inhibition of human HuH-7 cell growth in a cell viability assay, IC50 = 0.01232 μM. |
SANGER |
J-RT3-T3-5 |
Growth inhibition assay |
|
|
|
Inhibition of human J-RT3-T3-5 cell growth in a cell viability assay, IC50 = 0.01238 μM. |
SANGER |
VM-CUB-1 |
Growth inhibition assay |
|
|
|
Inhibition of human VM-CUB-1 cell growth in a cell viability assay, IC50 = 0.01267 μM. |
SANGER |
MOLT-16 |
Growth inhibition assay |
|
|
|
Inhibition of human MOLT-16 cell growth in a cell viability assay, IC50 = 0.01284 μM. |
SANGER |
KG-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KG-1 cell growth in a cell viability assay, IC50 = 0.0129 μM. |
SANGER |
P12-ICHIKAWA |
Growth inhibition assay |
|
|
|
Inhibition of human P12-ICHIKAWA cell growth in a cell viability assay, IC50 = 0.01301 μM. |
SANGER |
ACN |
Growth inhibition assay |
|
|
|
Inhibition of human ACN cell growth in a cell viability assay, IC50 = 0.01302 μM. |
SANGER |
COLO-684 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-684 cell growth in a cell viability assay, IC50 = 0.01331 μM. |
SANGER |
T-24 |
Growth inhibition assay |
|
|
|
Inhibition of human T-24 cell growth in a cell viability assay, IC50 = 0.01386 μM. |
SANGER |
AGS |
Growth inhibition assay |
|
|
|
Inhibition of human AGS cell growth in a cell viability assay, IC50 = 0.01411 μM. |
SANGER |
EW-13 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-13 cell growth in a cell viability assay, IC50 = 0.01454 μM. |
SANGER |
SW962 |
Growth inhibition assay |
|
|
|
Inhibition of human SW962 cell growth in a cell viability assay, IC50 = 0.01559 μM. |
SANGER |
EW-11 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-11 cell growth in a cell viability assay, IC50 = 0.0156 μM. |
SANGER |
RXF393 |
Growth inhibition assay |
|
|
|
Inhibition of human RXF393 cell growth in a cell viability assay, IC50 = 0.01566 μM. |
SANGER |
EoL-1-cell |
Growth inhibition assay |
|
|
|
Inhibition of human EoL-1-cell cell growth in a cell viability assay, IC50 = 0.0161 μM. |
SANGER |
KE-37 |
Growth inhibition assay |
|
|
|
Inhibition of human KE-37 cell growth in a cell viability assay, IC50 = 0.01651 μM. |
SANGER |
U-118-MG |
Growth inhibition assay |
|
|
|
Inhibition of human U-118-MG cell growth in a cell viability assay, IC50 = 0.0167 μM. |
SANGER |
DOHH-2 |
Growth inhibition assay |
|
|
|
Inhibition of human DOHH-2 cell growth in a cell viability assay, IC50 = 0.01682 μM. |
SANGER |
OS-RC-2 |
Growth inhibition assay |
|
|
|
Inhibition of human OS-RC-2 cell growth in a cell viability assay, IC50 = 0.01699 μM. |
SANGER |
NB7 |
Growth inhibition assay |
|
|
|
Inhibition of human NB7 cell growth in a cell viability assay, IC50 = 0.01788 μM. |
SANGER |
OC-314 |
Growth inhibition assay |
|
|
|
Inhibition of human OC-314 cell growth in a cell viability assay, IC50 = 0.01793 μM. |
SANGER |
HT-1080 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-1080 cell growth in a cell viability assay, IC50 = 0.01793 μM. |
SANGER |
MV-4-11 |
Growth inhibition assay |
|
|
|
Inhibition of human MV-4-11 cell growth in a cell viability assay, IC50 = 0.01888 μM. |
SANGER |
MN-60 |
Growth inhibition assay |
|
|
|
Inhibition of human MN-60 cell growth in a cell viability assay, IC50 = 0.01932 μM. |
SANGER |
A549 |
Growth inhibition assay |
|
|
|
Inhibition of human A549 cell growth in a cell viability assay, IC50 = 0.02019 μM. |
SANGER |
NTERA-S-cl-D1 |
Growth inhibition assay |
|
|
|
Inhibition of human NTERA-S-cl-D1 cell growth in a cell viability assay, IC50 = 0.02069 μM. |
SANGER |
NBsusSR |
Growth inhibition assay |
|
|
|
Inhibition of human NBsusSR cell growth in a cell viability assay, IC50 = 0.02134 μM. |
SANGER |
HD-MY-Z |
Growth inhibition assay |
|
|
|
Inhibition of human HD-MY-Z cell growth in a cell viability assay, IC50 = 0.0216 μM. |
SANGER |
EGI-1 |
Growth inhibition assay |
|
|
|
Inhibition of human EGI-1 cell growth in a cell viability assay, IC50 = 0.02199 μM. |
SANGER |
SF126 |
Growth inhibition assay |
|
|
|
Inhibition of human SF126 cell growth in a cell viability assay, IC50 = 0.02285 μM. |
SANGER |
HuO-3N1 |
Growth inhibition assay |
|
|
|
Inhibition of human HuO-3N1 cell growth in a cell viability assay, IC50 = 0.02302 μM. |
SANGER |
NCI-H1703 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1703 cell growth in a cell viability assay, IC50 = 0.02321 μM. |
SANGER |
NUGC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human NUGC-3 cell growth in a cell viability assay, IC50 = 0.02349 μM. |
SANGER |
ES1 |
Growth inhibition assay |
|
|
|
Inhibition of human ES1 cell growth in a cell viability assay, IC50 = 0.02454 μM. |
SANGER |
MC116 |
Growth inhibition assay |
|
|
|
Inhibition of human MC116 cell growth in a cell viability assay, IC50 = 0.02553 μM. |
SANGER |
HCC1419 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1419 cell growth in a cell viability assay, IC50 = 0.02585 μM. |
SANGER |
T98G |
Growth inhibition assay |
|
|
|
Inhibition of human T98G cell growth in a cell viability assay, IC50 = 0.02617 μM. |
SANGER |
A2058 |
Growth inhibition assay |
|
|
|
Inhibition of human A2058 cell growth in a cell viability assay, IC50 = 0.02655 μM. |
SANGER |
HT |
Growth inhibition assay |
|
|
|
Inhibition of human HT cell growth in a cell viability assay, IC50 = 0.02756 μM. |
SANGER |
PFSK-1 |
Growth inhibition assay |
|
|
|
Inhibition of human PFSK-1 cell growth in a cell viability assay, IC50 = 0.02772 μM. |
SANGER |
EW-16 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-16 cell growth in a cell viability assay, IC50 = 0.02857 μM. |
SANGER |
NCI-H82 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H82 cell growth in a cell viability assay, IC50 = 0.02882 μM. |
SANGER |
LU-134-A |
Growth inhibition assay |
|
|
|
Inhibition of human LU-134-A cell growth in a cell viability assay, IC50 = 0.0289 μM. |
SANGER |
RPMI-8866 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-8866 cell growth in a cell viability assay, IC50 = 0.03137 μM. |
SANGER |
BEN |
Growth inhibition assay |
|
|
|
Inhibition of human BEN cell growth in a cell viability assay, IC50 = 0.0315 μM. |
SANGER |
ETK-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ETK-1 cell growth in a cell viability assay, IC50 = 0.03178 μM. |
SANGER |
SW1088 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1088 cell growth in a cell viability assay, IC50 = 0.03184 μM. |
SANGER |
BPH-1 |
Growth inhibition assay |
|
|
|
Inhibition of human BPH-1 cell growth in a cell viability assay, IC50 = 0.03239 μM. |
SANGER |
ONS-76 |
Growth inhibition assay |
|
|
|
Inhibition of human ONS-76 cell growth in a cell viability assay, IC50 = 0.03303 μM. |
SANGER |
EFO-27 |
Growth inhibition assay |
|
|
|
Inhibition of human EFO-27 cell growth in a cell viability assay, IC50 = 0.03308 μM. |
SANGER |
GR-ST |
Growth inhibition assay |
|
|
|
Inhibition of human GR-ST cell growth in a cell viability assay, IC50 = 0.03335 μM. |
SANGER |
MEL-HO |
Growth inhibition assay |
|
|
|
Inhibition of human MEL-HO cell growth in a cell viability assay, IC50 = 0.03365 μM. |
SANGER |
MDA-MB-415 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-415 cell growth in a cell viability assay, IC50 = 0.03595 μM. |
SANGER |
ES4 |
Growth inhibition assay |
|
|
|
Inhibition of human ES4 cell growth in a cell viability assay, IC50 = 0.03776 μM. |
SANGER |
HSC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human HSC-3 cell growth in a cell viability assay, IC50 = 0.03869 μM. |
SANGER |
IGROV-1 |
Growth inhibition assay |
|
|
|
Inhibition of human IGROV-1 cell growth in a cell viability assay, IC50 = 0.03879 μM. |
SANGER |
A204 |
Growth inhibition assay |
|
|
|
Inhibition of human A204 cell growth in a cell viability assay, IC50 = 0.03885 μM. |
SANGER |
RPMI-7951 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-7951 cell growth in a cell viability assay, IC50 = 0.03897 μM. |
SANGER |
LB2241-RCC |
Growth inhibition assay |
|
|
|
Inhibition of human LB2241-RCC cell growth in a cell viability assay, IC50 = 0.03927 μM. |
SANGER |
CAL-39 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-39 cell growth in a cell viability assay, IC50 = 0.04012 μM. |
SANGER |
DOK |
Growth inhibition assay |
|
|
|
Inhibition of human DOK cell growth in a cell viability assay, IC50 = 0.04102 μM. |
SANGER |
YH-13 |
Growth inhibition assay |
|
|
|
Inhibition of human YH-13 cell growth in a cell viability assay, IC50 = 0.04108 μM. |
SANGER |
BV-173 |
Growth inhibition assay |
|
|
|
Inhibition of human BV-173 cell growth in a cell viability assay, IC50 = 0.04385 μM. |
SANGER |
NCI-H1793 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1793 cell growth in a cell viability assay, IC50 = 0.0457 μM. |
SANGER |
C32 |
Growth inhibition assay |
|
|
|
Inhibition of human C32 cell growth in a cell viability assay, IC50 = 0.04664 μM. |
SANGER |
RT-112 |
Growth inhibition assay |
|
|
|
Inhibition of human RT-112 cell growth in a cell viability assay, IC50 = 0.04709 μM. |
SANGER |
A101D |
Growth inhibition assay |
|
|
|
Inhibition of human A101D cell growth in a cell viability assay, IC50 = 0.04873 μM. |
SANGER |
EW-3 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-3 cell growth in a cell viability assay, IC50 = 0.04917 μM. |
SANGER |
HCE-T |
Growth inhibition assay |
|
|
|
Inhibition of human HCE-T cell growth in a cell viability assay, IC50 = 0.04917 μM. |
SANGER |
Mewo |
Growth inhibition assay |
|
|
|
Inhibition of human Mewo cell growth in a cell viability assay, IC50 = 0.04943 μM. |
SANGER |
KNS-62 |
Growth inhibition assay |
|
|
|
Inhibition of human KNS-62 cell growth in a cell viability assay, IC50 = 0.05037 μM. |
SANGER |
FTC-133 |
Growth inhibition assay |
|
|
|
Inhibition of human FTC-133 cell growth in a cell viability assay, IC50 = 0.05058 μM. |
SANGER |
KARPAS-45 |
Growth inhibition assay |
|
|
|
Inhibition of human KARPAS-45 cell growth in a cell viability assay, IC50 = 0.05134 μM. |
SANGER |
786-0 |
Growth inhibition assay |
|
|
|
Inhibition of human 786-0 cell growth in a cell viability assay, IC50 = 0.05169 μM. |
SANGER |
Daoy |
Growth inhibition assay |
|
|
|
Inhibition of human Daoy cell growth in a cell viability assay, IC50 = 0.05172 μM. |
SANGER |
CHP-212 |
Growth inhibition assay |
|
|
|
Inhibition of human CHP-212 cell growth in a cell viability assay, IC50 = 0.05243 μM. |
SANGER |
LU-139 |
Growth inhibition assay |
|
|
|
Inhibition of human LU-139 cell growth in a cell viability assay, IC50 = 0.05327 μM. |
SANGER |
HLE |
Growth inhibition assay |
|
|
|
Inhibition of human HLE cell growth in a cell viability assay, IC50 = 0.05394 μM. |
SANGER |
EM-2 |
Growth inhibition assay |
|
|
|
Inhibition of human EM-2 cell growth in a cell viability assay, IC50 = 0.05421 μM. |
SANGER |
COR-L105 |
Growth inhibition assay |
|
|
|
Inhibition of human COR-L105 cell growth in a cell viability assay, IC50 = 0.05447 μM. |
SANGER |
NCI-H1355 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1355 cell growth in a cell viability assay, IC50 = 0.05588 μM. |
SANGER |
KASUMI-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KASUMI-1 cell growth in a cell viability assay, IC50 = 0.05625 μM. |
SANGER |
MZ2-MEL |
Growth inhibition assay |
|
|
|
Inhibition of human MZ2-MEL cell growth in a cell viability assay, IC50 = 0.05687 μM. |
SANGER |
AN3-CA |
Growth inhibition assay |
|
|
|
Inhibition of human AN3-CA cell growth in a cell viability assay, IC50 = 0.05688 μM. |
SANGER |
NCI-H2126 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2126 cell growth in a cell viability assay, IC50 = 0.05801 μM. |
SANGER |
BCPAP |
Growth inhibition assay |
|
|
|
Inhibition of human BCPAP cell growth in a cell viability assay, IC50 = 0.05853 μM. |
SANGER |
MSTO-211H |
Growth inhibition assay |
|
|
|
Inhibition of human MSTO-211H cell growth in a cell viability assay, IC50 = 0.06008 μM. |
SANGER |
SF295 |
Growth inhibition assay |
|
|
|
Inhibition of human SF295 cell growth in a cell viability assay, IC50 = 0.06051 μM. |
SANGER |
ES5 |
Growth inhibition assay |
|
|
|
Inhibition of human ES5 cell growth in a cell viability assay, IC50 = 0.06142 μM. |
SANGER |
NCI-H526 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H526 cell growth in a cell viability assay, IC50 = 0.06156 μM. |
SANGER |
LB1047-RCC |
Growth inhibition assay |
|
|
|
Inhibition of human LB1047-RCC cell growth in a cell viability assay, IC50 = 0.06305 μM. |
SANGER |
KS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KS-1 cell growth in a cell viability assay, IC50 = 0.06346 μM. |
SANGER |
NCI-H1155 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1155 cell growth in a cell viability assay, IC50 = 0.06357 μM. |
SANGER |
SK-UT-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-UT-1 cell growth in a cell viability assay, IC50 = 0.06413 μM. |
SANGER |
23132-87 |
Growth inhibition assay |
|
|
|
Inhibition of human 23132-87 cell growth in a cell viability assay, IC50 = 0.06466 μM. |
SANGER |
Hs-578-T |
Growth inhibition assay |
|
|
|
Inhibition of human Hs-578-T cell growth in a cell viability assay, IC50 = 0.0659 μM. |
SANGER |
MEL-JUSO |
Growth inhibition assay |
|
|
|
Inhibition of human MEL-JUSO cell growth in a cell viability assay, IC50 = 0.06664 μM. |
SANGER |
HTC-C3 |
Growth inhibition assay |
|
|
|
Inhibition of human HTC-C3 cell growth in a cell viability assay, IC50 = 0.06822 μM. |
SANGER |
CAKI-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAKI-1 cell growth in a cell viability assay, IC50 = 0.06872 μM. |
SANGER |
UM-UC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human UM-UC-3 cell growth in a cell viability assay, IC50 = 0.06921 μM. |
SANGER |
U-2-OS |
Growth inhibition assay |
|
|
|
Inhibition of human U-2-OS cell growth in a cell viability assay, IC50 = 0.07023 μM. |
SANGER |
D-336MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-336MG cell growth in a cell viability assay, IC50 = 0.07595 μM. |
SANGER |
SK-MEL-24 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-24 cell growth in a cell viability assay, IC50 = 0.07702 μM. |
SANGER |
D-542MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-542MG cell growth in a cell viability assay, IC50 = 0.07792 μM. |
SANGER |
Becker |
Growth inhibition assay |
|
|
|
Inhibition of human Becker cell growth in a cell viability assay, IC50 = 0.07989 μM. |
SANGER |
EFM-19 |
Growth inhibition assay |
|
|
|
Inhibition of human EFM-19 cell growth in a cell viability assay, IC50 = 0.08146 μM. |
SANGER |
A4-Fuk |
Growth inhibition assay |
|
|
|
Inhibition of human A4-Fuk cell growth in a cell viability assay, IC50 = 0.08182 μM. |
SANGER |
TCCSUP |
Growth inhibition assay |
|
|
|
Inhibition of human TCCSUP cell growth in a cell viability assay, IC50 = 0.08233 μM. |
SANGER |
ES3 |
Growth inhibition assay |
|
|
|
Inhibition of human ES3 cell growth in a cell viability assay, IC50 = 0.0851 μM. |
SANGER |
ES7 |
Growth inhibition assay |
|
|
|
Inhibition of human ES7 cell growth in a cell viability assay, IC50 = 0.08585 μM. |
SANGER |
MEG-01 |
Growth inhibition assay |
|
|
|
Inhibition of human MEG-01 cell growth in a cell viability assay, IC50 = 0.08816 μM. |
SANGER |
G-401 |
Growth inhibition assay |
|
|
|
Inhibition of human G-401 cell growth in a cell viability assay, IC50 = 0.08896 μM. |
SANGER |
UMC-11 |
Growth inhibition assay |
|
|
|
Inhibition of human UMC-11 cell growth in a cell viability assay, IC50 = 0.08945 μM. |
SANGER |
GT3TKB |
Growth inhibition assay |
|
|
|
Inhibition of human GT3TKB cell growth in a cell viability assay, IC50 = 0.09059 μM. |
SANGER |
MHH-ES-1 |
Growth inhibition assay |
|
|
|
Inhibition of human MHH-ES-1 cell growth in a cell viability assay, IC50 = 0.0919 μM. |
SANGER |
NCI-H1693 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1693 cell growth in a cell viability assay, IC50 = 0.09217 μM. |
SANGER |
Ca9-22 |
Growth inhibition assay |
|
|
|
Inhibition of human Ca9-22 cell growth in a cell viability assay, IC50 = 0.09661 μM. |
SANGER |
NCI-H2030 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2030 cell growth in a cell viability assay, IC50 = 0.09807 μM. |
SANGER |
NB14 |
Growth inhibition assay |
|
|
|
Inhibition of human NB14 cell growth in a cell viability assay, IC50 = 0.10019 μM. |
SANGER |
HC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human HC-1 cell growth in a cell viability assay, IC50 = 0.1008 μM. |
SANGER |
SK-LU-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-LU-1 cell growth in a cell viability assay, IC50 = 0.10226 μM. |
SANGER |
SBC-5 |
Growth inhibition assay |
|
|
|
Inhibition of human SBC-5 cell growth in a cell viability assay, IC50 = 0.10306 μM. |
SANGER |
NCI-H1437 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1437 cell growth in a cell viability assay, IC50 = 0.1032 μM. |
SANGER |
S-117 |
Growth inhibition assay |
|
|
|
Inhibition of human S-117 cell growth in a cell viability assay, IC50 = 0.1053 μM. |
SANGER |
NCI-H1563 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1563 cell growth in a cell viability assay, IC50 = 0.10561 μM. |
SANGER |
SW620 |
Growth inhibition assay |
|
|
|
Inhibition of human SW620 cell growth in a cell viability assay, IC50 = 0.10642 μM. |
SANGER |
GI-1 |
Growth inhibition assay |
|
|
|
Inhibition of human GI-1 cell growth in a cell viability assay, IC50 = 0.10688 μM. |
SANGER |
T47D |
Growth inhibition assay |
|
|
|
Inhibition of human T47D cell growth in a cell viability assay, IC50 = 0.10746 μM. |
SANGER |
ME-180 |
Growth inhibition assay |
|
|
|
Inhibition of human ME-180 cell growth in a cell viability assay, IC50 = 0.10852 μM. |
SANGER |
NB5 |
Growth inhibition assay |
|
|
|
Inhibition of human NB5 cell growth in a cell viability assay, IC50 = 0.11132 μM. |
SANGER |
KP-4 |
Growth inhibition assay |
|
|
|
Inhibition of human KP-4 cell growth in a cell viability assay, IC50 = 0.11563 μM. |
SANGER |
NCI-H661 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H661 cell growth in a cell viability assay, IC50 = 0.11662 μM. |
SANGER |
CAL-62 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-62 cell growth in a cell viability assay, IC50 = 0.11695 μM. |
SANGER |
RPMI-2650 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-2650 cell growth in a cell viability assay, IC50 = 0.11723 μM. |
SANGER |
M059J |
Growth inhibition assay |
|
|
|
Inhibition of human M059J cell growth in a cell viability assay, IC50 = 0.11777 μM. |
SANGER |
CAL-54 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-54 cell growth in a cell viability assay, IC50 = 0.11846 μM. |
SANGER |
DMS-114 |
Growth inhibition assay |
|
|
|
Inhibition of human DMS-114 cell growth in a cell viability assay, IC50 = 0.11943 μM. |
SANGER |
LOXIMVI |
Growth inhibition assay |
|
|
|
Inhibition of human LOXIMVI cell growth in a cell viability assay, IC50 = 0.11987 μM. |
SANGER |
SF539 |
Growth inhibition assay |
|
|
|
Inhibition of human SF539 cell growth in a cell viability assay, IC50 = 0.12088 μM. |
SANGER |
IST-MEL1 |
Growth inhibition assay |
|
|
|
Inhibition of human IST-MEL1 cell growth in a cell viability assay, IC50 = 0.1232 μM. |
SANGER |
OVCAR-5 |
Growth inhibition assay |
|
|
|
Inhibition of human OVCAR-5 cell growth in a cell viability assay, IC50 = 0.12369 μM. |
SANGER |
LU-99A |
Growth inhibition assay |
|
|
|
Inhibition of human LU-99A cell growth in a cell viability assay, IC50 = 0.12493 μM. |
SANGER |
SK-N-AS |
Growth inhibition assay |
|
|
|
Inhibition of human SK-N-AS cell growth in a cell viability assay, IC50 = 0.12678 μM. |
SANGER |
SCC-15 |
Growth inhibition assay |
|
|
|
Inhibition of human SCC-15 cell growth in a cell viability assay, IC50 = 0.12817 μM. |
SANGER |
COLO-800 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-800 cell growth in a cell viability assay, IC50 = 0.12939 μM. |
SANGER |
SK-MEL-28 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-28 cell growth in a cell viability assay, IC50 = 0.13055 μM. |
SANGER |
NCI-H358 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H358 cell growth in a cell viability assay, IC50 = 0.13121 μM. |
SANGER |
MG-63 |
Growth inhibition assay |
|
|
|
Inhibition of human MG-63 cell growth in a cell viability assay, IC50 = 0.13434 μM. |
SANGER |
LN-405 |
Growth inhibition assay |
|
|
|
Inhibition of human LN-405 cell growth in a cell viability assay, IC50 = 0.13464 μM. |
SANGER |
RKO |
Growth inhibition assay |
|
|
|
Inhibition of human RKO cell growth in a cell viability assay, IC50 = 0.13548 μM. |
SANGER |
OVCAR-8 |
Growth inhibition assay |
|
|
|
Inhibition of human OVCAR-8 cell growth in a cell viability assay, IC50 = 0.13634 μM. |
SANGER |
TGBC1TKB |
Growth inhibition assay |
|
|
|
Inhibition of human TGBC1TKB cell growth in a cell viability assay, IC50 = 0.13688 μM. |
SANGER |
KNS-81-FD |
Growth inhibition assay |
|
|
|
Inhibition of human KNS-81-FD cell growth in a cell viability assay, IC50 = 0.13847 μM. |
SANGER |
KYSE-520 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-520 cell growth in a cell viability assay, IC50 = 0.13862 μM. |
SANGER |
TGBC24TKB |
Growth inhibition assay |
|
|
|
Inhibition of human TGBC24TKB cell growth in a cell viability assay, IC50 = 0.14146 μM. |
SANGER |
SJSA-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SJSA-1 cell growth in a cell viability assay, IC50 = 0.14331 μM. |
SANGER |
RD |
Growth inhibition assay |
|
|
|
Inhibition of human RD cell growth in a cell viability assay, IC50 = 0.14418 μM. |
SANGER |
HOS |
Growth inhibition assay |
|
|
|
Inhibition of human HOS cell growth in a cell viability assay, IC50 = 0.1455 μM. |
SANGER |
G-361 |
Growth inhibition assay |
|
|
|
Inhibition of human G-361 cell growth in a cell viability assay, IC50 = 0.14566 μM. |
SANGER |
J82 |
Growth inhibition assay |
|
|
|
Inhibition of human J82 cell growth in a cell viability assay, IC50 = 0.14803 μM. |
SANGER |
LXF-289 |
Growth inhibition assay |
|
|
|
Inhibition of human LXF-289 cell growth in a cell viability assay, IC50 = 0.14834 μM. |
SANGER |
KALS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KALS-1 cell growth in a cell viability assay, IC50 = 0.14918 μM. |
SANGER |
U-266 |
Growth inhibition assay |
|
|
|
Inhibition of human U-266 cell growth in a cell viability assay, IC50 = 0.15111 μM. |
SANGER |
NCI-H209 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H209 cell growth in a cell viability assay, IC50 = 0.15334 μM. |
SANGER |
PANC-10-05 |
Growth inhibition assay |
|
|
|
Inhibition of human PANC-10-05 cell growth in a cell viability assay, IC50 = 0.15461 μM. |
SANGER |
KYSE-140 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-140 cell growth in a cell viability assay, IC50 = 0.15573 μM. |
SANGER |
HEL |
Growth inhibition assay |
|
|
|
Inhibition of human HEL cell growth in a cell viability assay, IC50 = 0.15761 μM. |
SANGER |
HCC70 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC70 cell growth in a cell viability assay, IC50 = 0.15777 μM. |
SANGER |
D-263MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-263MG cell growth in a cell viability assay, IC50 = 0.15889 μM. |
SANGER |
A673 |
Growth inhibition assay |
|
|
|
Inhibition of human A673 cell growth in a cell viability assay, IC50 = 0.16072 μM. |
SANGER |
MZ7-mel |
Growth inhibition assay |
|
|
|
Inhibition of human MZ7-mel cell growth in a cell viability assay, IC50 = 0.16074 μM. |
SANGER |
KYSE-270 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-270 cell growth in a cell viability assay, IC50 = 0.16428 μM. |
SANGER |
KOSC-2 |
Growth inhibition assay |
|
|
|
Inhibition of human KOSC-2 cell growth in a cell viability assay, IC50 = 0.16696 μM. |
SANGER |
NOMO-1 |
Growth inhibition assay |
|
|
|
Inhibition of human NOMO-1 cell growth in a cell viability assay, IC50 = 0.16756 μM. |
SANGER |
SNU-423 |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-423 cell growth in a cell viability assay, IC50 = 0.17342 μM. |
SANGER |
SNU-387 |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-387 cell growth in a cell viability assay, IC50 = 0.17525 μM. |
SANGER |
NCI-N87 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-N87 cell growth in a cell viability assay, IC50 = 0.17528 μM. |
SANGER |
HuO9 |
Growth inhibition assay |
|
|
|
Inhibition of human HuO9 cell growth in a cell viability assay, IC50 = 0.17744 μM. |
SANGER |
KYSE-410 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-410 cell growth in a cell viability assay, IC50 = 0.1804 μM. |
SANGER |
NCI-H1648 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1648 cell growth in a cell viability assay, IC50 = 0.18154 μM. |
SANGER |
A427 |
Growth inhibition assay |
|
|
|
Inhibition of human A427 cell growth in a cell viability assay, IC50 = 0.18267 μM. |
SANGER |
SN12C |
Growth inhibition assay |
|
|
|
Inhibition of human SN12C cell growth in a cell viability assay, IC50 = 0.18328 μM. |
SANGER |
LNCaP-Clone-FGC |
Growth inhibition assay |
|
|
|
Inhibition of human LNCaP-Clone-FGC cell growth in a cell viability assay, IC50 = 0.18407 μM. |
SANGER |
SW13 |
Growth inhibition assay |
|
|
|
Inhibition of human SW13 cell growth in a cell viability assay, IC50 = 0.18571 μM. |
SANGER |
NCI-H1299 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1299 cell growth in a cell viability assay, IC50 = 0.18583 μM. |
SANGER |
RVH-421 |
Growth inhibition assay |
|
|
|
Inhibition of human RVH-421 cell growth in a cell viability assay, IC50 = 0.18731 μM. |
SANGER |
TE-6 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-6 cell growth in a cell viability assay, IC50 = 0.1889 μM. |
SANGER |
SW1710 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1710 cell growth in a cell viability assay, IC50 = 0.18922 μM. |
SANGER |
BHT-101 |
Growth inhibition assay |
|
|
|
Inhibition of human BHT-101 cell growth in a cell viability assay, IC50 = 0.19717 μM. |
SANGER |
NKM-1 |
Growth inhibition assay |
|
|
|
Inhibition of human NKM-1 cell growth in a cell viability assay, IC50 = 0.19798 μM. |
SANGER |
HSC-2 |
Growth inhibition assay |
|
|
|
Inhibition of human HSC-2 cell growth in a cell viability assay, IC50 = 0.19998 μM. |
SANGER |
TE-8 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-8 cell growth in a cell viability assay, IC50 = 0.20019 μM. |
SANGER |
EW-1 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-1 cell growth in a cell viability assay, IC50 = 0.20094 μM. |
SANGER |
NB10 |
Growth inhibition assay |
|
|
|
Inhibition of human NB10 cell growth in a cell viability assay, IC50 = 0.20721 μM. |
SANGER |
NMC-G1 |
Growth inhibition assay |
|
|
|
Inhibition of human NMC-G1 cell growth in a cell viability assay, IC50 = 0.20822 μM. |
SANGER |
DBTRG-05MG |
Growth inhibition assay |
|
|
|
Inhibition of human DBTRG-05MG cell growth in a cell viability assay, IC50 = 0.21031 μM. |
SANGER |
22RV1 |
Growth inhibition assay |
|
|
|
Inhibition of human 22RV1 cell growth in a cell viability assay, IC50 = 0.21194 μM. |
SANGER |
SK-MES-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MES-1 cell growth in a cell viability assay, IC50 = 0.21477 μM. |
SANGER |
HOP-92 |
Growth inhibition assay |
|
|
|
Inhibition of human HOP-92 cell growth in a cell viability assay, IC50 = 0.22333 μM. |
SANGER |
KU-19-19 |
Growth inhibition assay |
|
|
|
Inhibition of human KU-19-19 cell growth in a cell viability assay, IC50 = 0.22839 μM. |
SANGER |
OE33 |
Growth inhibition assay |
|
|
|
Inhibition of human OE33 cell growth in a cell viability assay, IC50 = 0.22972 μM. |
SANGER |
KMOE-2 |
Growth inhibition assay |
|
|
|
Inhibition of human KMOE-2 cell growth in a cell viability assay, IC50 = 0.23075 μM. |
SANGER |
OAW-42 |
Growth inhibition assay |
|
|
|
Inhibition of human OAW-42 cell growth in a cell viability assay, IC50 = 0.24014 μM. |
SANGER |
OCI-AML2 |
Growth inhibition assay |
|
|
|
Inhibition of human OCI-AML2 cell growth in a cell viability assay, IC50 = 0.2416 μM. |
SANGER |
Detroit562 |
Growth inhibition assay |
|
|
|
Inhibition of human Detroit562 cell growth in a cell viability assay, IC50 = 0.24192 μM. |
SANGER |
SW900 |
Growth inhibition assay |
|
|
|
Inhibition of human SW900 cell growth in a cell viability assay, IC50 = 0.24579 μM. |
SANGER |
D-392MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-392MG cell growth in a cell viability assay, IC50 = 0.24835 μM. |
SANGER |
VMRC-RCZ |
Growth inhibition assay |
|
|
|
Inhibition of human VMRC-RCZ cell growth in a cell viability assay, IC50 = 0.24925 μM. |
SANGER |
GCIY |
Growth inhibition assay |
|
|
|
Inhibition of human GCIY cell growth in a cell viability assay, IC50 = 0.25375 μM. |
SANGER |
CAL-72 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-72 cell growth in a cell viability assay, IC50 = 0.26469 μM. |
SANGER |
ES6 |
Growth inhibition assay |
|
|
|
Inhibition of human ES6 cell growth in a cell viability assay, IC50 = 0.26642 μM. |
SANGER |
BFTC-909 |
Growth inhibition assay |
|
|
|
Inhibition of human BFTC-909 cell growth in a cell viability assay, IC50 = 0.27006 μM. |
SANGER |
SK-MEL-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-1 cell growth in a cell viability assay, IC50 = 0.27111 μM. |
SANGER |
HN |
Growth inhibition assay |
|
|
|
Inhibition of human HN cell growth in a cell viability assay, IC50 = 0.27231 μM. |
SANGER |
KP-N-YS |
Growth inhibition assay |
|
|
|
Inhibition of human KP-N-YS cell growth in a cell viability assay, IC50 = 0.27292 μM. |
SANGER |
KNS-42 |
Growth inhibition assay |
|
|
|
Inhibition of human KNS-42 cell growth in a cell viability assay, IC50 = 0.27293 μM. |
SANGER |
COLO-792 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-792 cell growth in a cell viability assay, IC50 = 0.27319 μM. |
SANGER |
CAL-33 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-33 cell growth in a cell viability assay, IC50 = 0.27442 μM. |
SANGER |
NCI-H2452 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2452 cell growth in a cell viability assay, IC50 = 0.27712 μM. |
SANGER |
NCI-H1838 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1838 cell growth in a cell viability assay, IC50 = 0.2785 μM. |
SANGER |
ZR-75-30 |
Growth inhibition assay |
|
|
|
Inhibition of human ZR-75-30 cell growth in a cell viability assay, IC50 = 0.28283 μM. |
SANGER |
SK-HEP-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-HEP-1 cell growth in a cell viability assay, IC50 = 0.28292 μM. |
SANGER |
ACHN |
Growth inhibition assay |
|
|
|
Inhibition of human ACHN cell growth in a cell viability assay, IC50 = 0.28315 μM. |
SANGER |
YKG-1 |
Growth inhibition assay |
|
|
|
Inhibition of human YKG-1 cell growth in a cell viability assay, IC50 = 0.28388 μM. |
SANGER |
D-247MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-247MG cell growth in a cell viability assay, IC50 = 0.28825 μM. |
SANGER |
COLO-680N |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-680N cell growth in a cell viability assay, IC50 = 0.2902 μM. |
SANGER |
EW-24 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-24 cell growth in a cell viability assay, IC50 = 0.29231 μM. |
SANGER |
KGN |
Growth inhibition assay |
|
|
|
Inhibition of human KGN cell growth in a cell viability assay, IC50 = 0.29451 μM. |
SANGER |
MIA-PaCa-2 |
Growth inhibition assay |
|
|
|
Inhibition of human MIA-PaCa-2 cell growth in a cell viability assay, IC50 = 0.29587 μM. |
SANGER |
SiHa |
Growth inhibition assay |
|
|
|
Inhibition of human SiHa cell growth in a cell viability assay, IC50 = 0.29993 μM. |
SANGER |
MS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human MS-1 cell growth in a cell viability assay, IC50 = 0.30154 μM. |
SANGER |
DK-MG |
Growth inhibition assay |
|
|
|
Inhibition of human DK-MG cell growth in a cell viability assay, IC50 = 0.30508 μM. |
SANGER |
HL-60 |
Growth inhibition assay |
|
|
|
Inhibition of human HL-60 cell growth in a cell viability assay, IC50 = 0.30635 μM. |
SANGER |
NCI-H446 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H446 cell growth in a cell viability assay, IC50 = 0.30806 μM. |
SANGER |
KINGS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KINGS-1 cell growth in a cell viability assay, IC50 = 0.3103 μM. |
SANGER |
EW-22 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-22 cell growth in a cell viability assay, IC50 = 0.31117 μM. |
SANGER |
HT-3 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-3 cell growth in a cell viability assay, IC50 = 0.31593 μM. |
SANGER |
TI-73 |
Growth inhibition assay |
|
|
|
Inhibition of human TI-73 cell growth in a cell viability assay, IC50 = 0.31672 μM. |
SANGER |
PC-14 |
Growth inhibition assay |
|
|
|
Inhibition of human PC-14 cell growth in a cell viability assay, IC50 = 0.31899 μM. |
SANGER |
ABC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ABC-1 cell growth in a cell viability assay, IC50 = 0.32037 μM. |
SANGER |
AU565 |
Growth inhibition assay |
|
|
|
Inhibition of human AU565 cell growth in a cell viability assay, IC50 = 0.32111 μM. |
SANGER |
IST-MES1 |
Growth inhibition assay |
|
|
|
Inhibition of human IST-MES1 cell growth in a cell viability assay, IC50 = 0.32517 μM. |
SANGER |
LK-2 |
Growth inhibition assay |
|
|
|
Inhibition of human LK-2 cell growth in a cell viability assay, IC50 = 0.32518 μM. |
SANGER |
TK10 |
Growth inhibition assay |
|
|
|
Inhibition of human TK10 cell growth in a cell viability assay, IC50 = 0.32537 μM. |
SANGER |
TE-5 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-5 cell growth in a cell viability assay, IC50 = 0.3257 μM. |
SANGER |
8505C |
Growth inhibition assay |
|
|
|
Inhibition of human 8505C cell growth in a cell viability assay, IC50 = 0.32614 μM. |
SANGER |
SW626 |
Growth inhibition assay |
|
|
|
Inhibition of human SW626 cell growth in a cell viability assay, IC50 = 0.32669 μM. |
SANGER |
647-V |
Growth inhibition assay |
|
|
|
Inhibition of human 647-V cell growth in a cell viability assay, IC50 = 0.33189 μM. |
SANGER |
639-V |
Growth inhibition assay |
|
|
|
Inhibition of human 639-V cell growth in a cell viability assay, IC50 = 0.34085 μM. |
SANGER |
TE-11 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-11 cell growth in a cell viability assay, IC50 = 0.34108 μM. |
SANGER |
NCI-H1304 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1304 cell growth in a cell viability assay, IC50 = 0.34564 μM. |
SANGER |
JEG-3 |
Growth inhibition assay |
|
|
|
Inhibition of human JEG-3 cell growth in a cell viability assay, IC50 = 0.34655 μM. |
SANGER |
OCUB-M |
Growth inhibition assay |
|
|
|
Inhibition of human OCUB-M cell growth in a cell viability assay, IC50 = 0.35038 μM. |
SANGER |
CAL-27 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-27 cell growth in a cell viability assay, IC50 = 0.35051 μM. |
SANGER |
MDA-MB-175-VII |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-175-VII cell growth in a cell viability assay, IC50 = 0.3543 μM. |
SANGER |
HuP-T3 |
Growth inhibition assay |
|
|
|
Inhibition of human HuP-T3 cell growth in a cell viability assay, IC50 = 0.35658 μM. |
SANGER |
HEC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human HEC-1 cell growth in a cell viability assay, IC50 = 0.36355 μM. |
SANGER |
BHY |
Growth inhibition assay |
|
|
|
Inhibition of human BHY cell growth in a cell viability assay, IC50 = 0.3648 μM. |
SANGER |
NCI-H28 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H28 cell growth in a cell viability assay, IC50 = 0.36823 μM. |
SANGER |
JAR |
Growth inhibition assay |
|
|
|
Inhibition of human JAR cell growth in a cell viability assay, IC50 = 0.38211 μM. |
SANGER |
DSH1 |
Growth inhibition assay |
|
|
|
Inhibition of human DSH1 cell growth in a cell viability assay, IC50 = 0.38616 μM. |
SANGER |
PSN1 |
Growth inhibition assay |
|
|
|
Inhibition of human PSN1 cell growth in a cell viability assay, IC50 = 0.38725 μM. |
SANGER |
SCH |
Growth inhibition assay |
|
|
|
Inhibition of human SCH cell growth in a cell viability assay, IC50 = 0.38863 μM. |
SANGER |
C-33-A |
Growth inhibition assay |
|
|
|
Inhibition of human C-33-A cell growth in a cell viability assay, IC50 = 0.39213 μM. |
SANGER |
769-P |
Growth inhibition assay |
|
|
|
Inhibition of human 769-P cell growth in a cell viability assay, IC50 = 0.39425 μM. |
SANGER |
Calu-3 |
Growth inhibition assay |
|
|
|
Inhibition of human Calu-3 cell growth in a cell viability assay, IC50 = 0.40206 μM. |
SANGER |
NCI-H2170 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2170 cell growth in a cell viability assay, IC50 = 0.4047 μM. |
SANGER |
AM-38 |
Growth inhibition assay |
|
|
|
Inhibition of human AM-38 cell growth in a cell viability assay, IC50 = 0.40809 μM. |
SANGER |
8-MG-BA |
Growth inhibition assay |
|
|
|
Inhibition of human 8-MG-BA cell growth in a cell viability assay, IC50 = 0.40843 μM. |
SANGER |
SNB75 |
Growth inhibition assay |
|
|
|
Inhibition of human SNB75 cell growth in a cell viability assay, IC50 = 0.4126 μM. |
SANGER |
U251 |
Growth inhibition assay |
|
|
|
Inhibition of human U251 cell growth in a cell viability assay, IC50 = 0.41985 μM. |
SANGER |
CAL-51 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-51 cell growth in a cell viability assay, IC50 = 0.42586 μM. |
SANGER |
D-423MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-423MG cell growth in a cell viability assay, IC50 = 0.4302 μM. |
SANGER |
SW982 |
Growth inhibition assay |
|
|
|
Inhibition of human SW982 cell growth in a cell viability assay, IC50 = 0.44068 μM. |
SANGER |
A498 |
Growth inhibition assay |
|
|
|
Inhibition of human A498 cell growth in a cell viability assay, IC50 = 0.44076 μM. |
SANGER |
KYSE-180 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-180 cell growth in a cell viability assay, IC50 = 0.45093 μM. |
SANGER |
NCI-H1092 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1092 cell growth in a cell viability assay, IC50 = 0.45219 μM. |
SANGER |
M14 |
Growth inhibition assay |
|
|
|
Inhibition of human M14 cell growth in a cell viability assay, IC50 = 0.46306 μM. |
SANGER |
LC-2-ad |
Growth inhibition assay |
|
|
|
Inhibition of human LC-2-ad cell growth in a cell viability assay, IC50 = 0.46687 μM. |
SANGER |
SK-OV-3 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-OV-3 cell growth in a cell viability assay, IC50 = 0.46759 μM. |
SANGER |
HAL-01 |
Growth inhibition assay |
|
|
|
Inhibition of human HAL-01 cell growth in a cell viability assay, IC50 = 0.46909 μM. |
SANGER |
NCI-H727 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H727 cell growth in a cell viability assay, IC50 = 0.47186 μM. |
SANGER |
MFE-280 |
Growth inhibition assay |
|
|
|
Inhibition of human MFE-280 cell growth in a cell viability assay, IC50 = 0.47429 μM. |
SANGER |
LU-135 |
Growth inhibition assay |
|
|
|
Inhibition of human LU-135 cell growth in a cell viability assay, IC50 = 0.47755 μM. |
SANGER |
BB49-HNC |
Growth inhibition assay |
|
|
|
Inhibition of human BB49-HNC cell growth in a cell viability assay, IC50 = 0.48208 μM. |
SANGER |
RH-1 |
Growth inhibition assay |
|
|
|
Inhibition of human RH-1 cell growth in a cell viability assay, IC50 = 0.48724 μM. |
SANGER |
SW1783 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1783 cell growth in a cell viability assay, IC50 = 0.48745 μM. |
SANGER |
EW-18 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-18 cell growth in a cell viability assay, IC50 = 0.49124 μM. |
SANGER |
SNU-449 |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-449 cell growth in a cell viability assay, IC50 = 0.49252 μM. |
SANGER |
NH-12 |
Growth inhibition assay |
|
|
|
Inhibition of human NH-12 cell growth in a cell viability assay, IC50 = 0.49319 μM. |
SANGER |
SCC-4 |
Growth inhibition assay |
|
|
|
Inhibition of human SCC-4 cell growth in a cell viability assay, IC50 = 0.49591 μM. |
SANGER |
OMC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human OMC-1 cell growth in a cell viability assay, IC50 = 0.501 μM. |
SANGER |
SW756 |
Growth inhibition assay |
|
|
|
Inhibition of human SW756 cell growth in a cell viability assay, IC50 = 0.50718 μM. |
SANGER |
HCC1806 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1806 cell growth in a cell viability assay, IC50 = 0.50891 μM. |
SANGER |
WM-115 |
Growth inhibition assay |
|
|
|
Inhibition of human WM-115 cell growth in a cell viability assay, IC50 = 0.51096 μM. |
SANGER |
LB831-BLC |
Growth inhibition assay |
|
|
|
Inhibition of human LB831-BLC cell growth in a cell viability assay, IC50 = 0.51457 μM. |
SANGER |
EC-GI-10 |
Growth inhibition assay |
|
|
|
Inhibition of human EC-GI-10 cell growth in a cell viability assay, IC50 = 0.5201 μM. |
SANGER |
GB-1 |
Growth inhibition assay |
|
|
|
Inhibition of human GB-1 cell growth in a cell viability assay, IC50 = 0.53479 μM. |
SANGER |
SF268 |
Growth inhibition assay |
|
|
|
Inhibition of human SF268 cell growth in a cell viability assay, IC50 = 0.54005 μM. |
SANGER |
NB13 |
Growth inhibition assay |
|
|
|
Inhibition of human NB13 cell growth in a cell viability assay, IC50 = 0.54084 μM. |
SANGER |
SH-4 |
Growth inhibition assay |
|
|
|
Inhibition of human SH-4 cell growth in a cell viability assay, IC50 = 0.54115 μM. |
SANGER |
KYSE-510 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-510 cell growth in a cell viability assay, IC50 = 0.54347 μM. |
SANGER |
KYSE-450 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-450 cell growth in a cell viability assay, IC50 = 0.54664 μM. |
SANGER |
RERF-LC-MS |
Growth inhibition assay |
|
|
|
Inhibition of human RERF-LC-MS cell growth in a cell viability assay, IC50 = 0.5499 μM. |
SANGER |
NCI-H1650 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1650 cell growth in a cell viability assay, IC50 = 0.55213 μM. |
SANGER |
GI-ME-N |
Growth inhibition assay |
|
|
|
Inhibition of human GI-ME-N cell growth in a cell viability assay, IC50 = 0.55384 μM. |
SANGER |
EKVX |
Growth inhibition assay |
|
|
|
Inhibition of human EKVX cell growth in a cell viability assay, IC50 = 0.55387 μM. |
SANGER |
DU-145 |
Growth inhibition assay |
|
|
|
Inhibition of human DU-145 cell growth in a cell viability assay, IC50 = 0.55743 μM. |
SANGER |
NCI-H1651 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1651 cell growth in a cell viability assay, IC50 = 0.56343 μM. |
SANGER |
MCF7 |
Growth inhibition assay |
|
|
|
Inhibition of human MCF7 cell growth in a cell viability assay, IC50 = 0.56969 μM. |
SANGER |
MFM-223 |
Growth inhibition assay |
|
|
|
Inhibition of human MFM-223 cell growth in a cell viability assay, IC50 = 0.5774 μM. |
SANGER |
KM-H2 |
Growth inhibition assay |
|
|
|
Inhibition of human KM-H2 cell growth in a cell viability assay, IC50 = 0.57756 μM. |
SANGER |
ECC10 |
Growth inhibition assay |
|
|
|
Inhibition of human ECC10 cell growth in a cell viability assay, IC50 = 0.5851 μM. |
SANGER |
C2BBe1 |
Growth inhibition assay |
|
|
|
Inhibition of human C2BBe1 cell growth in a cell viability assay, IC50 = 0.58687 μM. |
SANGER |
SK-PN-DW |
Growth inhibition assay |
|
|
|
Inhibition of human SK-PN-DW cell growth in a cell viability assay, IC50 = 0.59283 μM. |
SANGER |
MPP-89 |
Growth inhibition assay |
|
|
|
Inhibition of human MPP-89 cell growth in a cell viability assay, IC50 = 0.59386 μM. |
SANGER |
MKN45 |
Growth inhibition assay |
|
|
|
Inhibition of human MKN45 cell growth in a cell viability assay, IC50 = 0.59903 μM. |
SANGER |
SK-MEL-2 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-2 cell growth in a cell viability assay, IC50 = 0.60178 μM. |
SANGER |
GMS-10 |
Growth inhibition assay |
|
|
|
Inhibition of human GMS-10 cell growth in a cell viability assay, IC50 = 0.61623 μM. |
SANGER |
SW48 |
Growth inhibition assay |
|
|
|
Inhibition of human SW48 cell growth in a cell viability assay, IC50 = 0.62038 μM. |
SANGER |
5637 |
Growth inhibition assay |
|
|
|
Inhibition of human 5637 cell growth in a cell viability assay, IC50 = 0.62466 μM. |
SANGER |
P30-OHK |
Growth inhibition assay |
|
|
|
Inhibition of human P30-OHK cell growth in a cell viability assay, IC50 = 0.64188 μM. |
SANGER |
HCC2218 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC2218 cell growth in a cell viability assay, IC50 = 0.6562 μM. |
SANGER |
SK-MEL-3 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-3 cell growth in a cell viability assay, IC50 = 0.66112 μM. |
SANGER |
A431 |
Growth inhibition assay |
|
|
|
Inhibition of human A431 cell growth in a cell viability assay, IC50 = 0.66405 μM. |
SANGER |
MKN1 |
Growth inhibition assay |
|
|
|
Inhibition of human MKN1 cell growth in a cell viability assay, IC50 = 0.67663 μM. |
SANGER |
NCI-H1792 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1792 cell growth in a cell viability assay, IC50 = 0.67992 μM. |
SANGER |
MDA-MB-231 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-231 cell growth in a cell viability assay, IC50 = 0.68339 μM. |
SANGER |
PANC-08-13 |
Growth inhibition assay |
|
|
|
Inhibition of human PANC-08-13 cell growth in a cell viability assay, IC50 = 0.69499 μM. |
SANGER |
SW1463 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1463 cell growth in a cell viability assay, IC50 = 0.70213 μM. |
SANGER |
NCI-H2228 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2228 cell growth in a cell viability assay, IC50 = 0.71151 μM. |
SANGER |
HPAF-II |
Growth inhibition assay |
|
|
|
Inhibition of human HPAF-II cell growth in a cell viability assay, IC50 = 0.71172 μM. |
SANGER |
TE-12 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-12 cell growth in a cell viability assay, IC50 = 0.7127 μM. |
SANGER |
SCC-25 |
Growth inhibition assay |
|
|
|
Inhibition of human SCC-25 cell growth in a cell viability assay, IC50 = 0.72229 μM. |
SANGER |
KY821 |
Growth inhibition assay |
|
|
|
Inhibition of human KY821 cell growth in a cell viability assay, IC50 = 0.7258 μM. |
SANGER |
NOS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human NOS-1 cell growth in a cell viability assay, IC50 = 0.72704 μM. |
SANGER |
DMS-273 |
Growth inhibition assay |
|
|
|
Inhibition of human DMS-273 cell growth in a cell viability assay, IC50 = 0.72972 μM. |
SANGER |
SNU-C2B |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-C2B cell growth in a cell viability assay, IC50 = 0.74246 μM. |
SANGER |
KYSE-70 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-70 cell growth in a cell viability assay, IC50 = 0.74477 μM. |
SANGER |
COLO-741 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-741 cell growth in a cell viability assay, IC50 = 0.74907 μM. |
SANGER |
NCI-H520 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H520 cell growth in a cell viability assay, IC50 = 0.75859 μM. |
SANGER |
NCI-H1573 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1573 cell growth in a cell viability assay, IC50 = 0.76634 μM. |
SANGER |
IGR-1 |
Growth inhibition assay |
|
|
|
Inhibition of human IGR-1 cell growth in a cell viability assay, IC50 = 0.76716 μM. |
SANGER |
H-EMC-SS |
Growth inhibition assay |
|
|
|
Inhibition of human H-EMC-SS cell growth in a cell viability assay, IC50 = 0.77051 μM. |
SANGER |
MDA-MB-453 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-453 cell growth in a cell viability assay, IC50 = 0.77688 μM. |
SANGER |
NCI-H23 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H23 cell growth in a cell viability assay, IC50 = 0.77846 μM. |
SANGER |
NCI-H1581 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1581 cell growth in a cell viability assay, IC50 = 0.77909 μM. |
SANGER |
SKG-IIIa |
Growth inhibition assay |
|
|
|
Inhibition of human SKG-IIIa cell growth in a cell viability assay, IC50 = 0.77912 μM. |
SANGER |
NCI-H810 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H810 cell growth in a cell viability assay, IC50 = 0.78045 μM. |
SANGER |
SW1990 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1990 cell growth in a cell viability assay, IC50 = 0.78173 μM. |
SANGER |
BFTC-905 |
Growth inhibition assay |
|
|
|
Inhibition of human BFTC-905 cell growth in a cell viability assay, IC50 = 0.78421 μM. |
SANGER |
BALL-1 |
Growth inhibition assay |
|
|
|
Inhibition of human BALL-1 cell growth in a cell viability assay, IC50 = 0.78606 μM. |
SANGER |
BxPC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human BxPC-3 cell growth in a cell viability assay, IC50 = 0.78715 μM. |
SANGER |
CAL-12T |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-12T cell growth in a cell viability assay, IC50 = 0.79984 μM. |
SANGER |
UACC-257 |
Growth inhibition assay |
|
|
|
Inhibition of human UACC-257 cell growth in a cell viability assay, IC50 = 0.81865 μM. |
SANGER |
HT-1376 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-1376 cell growth in a cell viability assay, IC50 = 0.82639 μM. |
SANGER |
ChaGo-K-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ChaGo-K-1 cell growth in a cell viability assay, IC50 = 0.84188 μM. |
SANGER |
CTV-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CTV-1 cell growth in a cell viability assay, IC50 = 0.85473 μM. |
SANGER |
LB771-HNC |
Growth inhibition assay |
|
|
|
Inhibition of human LB771-HNC cell growth in a cell viability assay, IC50 = 0.85515 μM. |
SANGER |
KARPAS-299 |
Growth inhibition assay |
|
|
|
Inhibition of human KARPAS-299 cell growth in a cell viability assay, IC50 = 0.87357 μM. |
SANGER |
KM12 |
Growth inhibition assay |
|
|
|
Inhibition of human KM12 cell growth in a cell viability assay, IC50 = 0.878 μM. |
SANGER |
CAPAN-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAPAN-1 cell growth in a cell viability assay, IC50 = 0.88166 μM. |
SANGER |
RO82-W-1 |
Growth inhibition assay |
|
|
|
Inhibition of human RO82-W-1 cell growth in a cell viability assay, IC50 = 0.89683 μM. |
SANGER |
LCLC-97TM1 |
Growth inhibition assay |
|
|
|
Inhibition of human LCLC-97TM1 cell growth in a cell viability assay, IC50 = 0.90513 μM. |
SANGER |
EPLC-272H |
Growth inhibition assay |
|
|
|
Inhibition of human EPLC-272H cell growth in a cell viability assay, IC50 = 0.92117 μM. |
SANGER |
L-428 |
Growth inhibition assay |
|
|
|
Inhibition of human L-428 cell growth in a cell viability assay, IC50 = 0.95936 μM. |
SANGER |
MKN28 |
Growth inhibition assay |
|
|
|
Inhibition of human MKN28 cell growth in a cell viability assay, IC50 = 0.97996 μM. |
SANGER |
BT-474 |
Growth inhibition assay |
|
|
|
Inhibition of human BT-474 cell growth in a cell viability assay, IC50 = 0.99197 μM. |
SANGER |
SK-N-DZ |
Growth inhibition assay |
|
|
|
Inhibition of human SK-N-DZ cell growth in a cell viability assay, IC50 = 0.99775 μM. |
SANGER |
BT-20 |
Growth inhibition assay |
|
|
|
Inhibition of human BT-20 cell growth in a cell viability assay, IC50 = 1.00073 μM. |
SANGER |
MMAC-SF |
Growth inhibition assay |
|
|
|
Inhibition of human MMAC-SF cell growth in a cell viability assay, IC50 = 1.00439 μM. |
SANGER |
NCI-H596 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H596 cell growth in a cell viability assay, IC50 = 1.03978 μM. |
SANGER |
CAL-120 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-120 cell growth in a cell viability assay, IC50 = 1.0404 μM. |
SANGER |
SW954 |
Growth inhibition assay |
|
|
|
Inhibition of human SW954 cell growth in a cell viability assay, IC50 = 1.13951 μM. |
SANGER |
AsPC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human AsPC-1 cell growth in a cell viability assay, IC50 = 1.15211 μM. |
SANGER |
A172 |
Growth inhibition assay |
|
|
|
Inhibition of human A172 cell growth in a cell viability assay, IC50 = 1.15653 μM. |
SANGER |
SK-N-FI |
Growth inhibition assay |
|
|
|
Inhibition of human SK-N-FI cell growth in a cell viability assay, IC50 = 1.16634 μM. |
SANGER |
RMG-I |
Growth inhibition assay |
|
|
|
Inhibition of human RMG-I cell growth in a cell viability assay, IC50 = 1.1686 μM. |
SANGER |
HDLM-2 |
Growth inhibition assay |
|
|
|
Inhibition of human HDLM-2 cell growth in a cell viability assay, IC50 = 1.16874 μM. |
SANGER |
Ca-Ski |
Growth inhibition assay |
|
|
|
Inhibition of human Ca-Ski cell growth in a cell viability assay, IC50 = 1.18041 μM. |
SANGER |
NY |
Growth inhibition assay |
|
|
|
Inhibition of human NY cell growth in a cell viability assay, IC50 = 1.18605 μM. |
SANGER |
TE-1 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-1 cell growth in a cell viability assay, IC50 = 1.2082 μM. |
SANGER |
NCI-H2342 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2342 cell growth in a cell viability assay, IC50 = 1.20932 μM. |
SANGER |
GOTO |
Growth inhibition assay |
|
|
|
Inhibition of human GOTO cell growth in a cell viability assay, IC50 = 1.2159 μM. |
SANGER |
NCI-H226 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H226 cell growth in a cell viability assay, IC50 = 1.24003 μM. |
SANGER |
NCI-H1623 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1623 cell growth in a cell viability assay, IC50 = 1.27466 μM. |
SANGER |
LCLC-103H |
Growth inhibition assay |
|
|
|
Inhibition of human LCLC-103H cell growth in a cell viability assay, IC50 = 1.28798 μM. |
SANGER |
EFO-21 |
Growth inhibition assay |
|
|
|
Inhibition of human EFO-21 cell growth in a cell viability assay, IC50 = 1.29934 μM. |
SANGER |
NCI-H747 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H747 cell growth in a cell viability assay, IC50 = 1.31678 μM. |
SANGER |
CaR-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CaR-1 cell growth in a cell viability assay, IC50 = 1.32211 μM. |
SANGER |
HCC38 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC38 cell growth in a cell viability assay, IC50 = 1.32574 μM. |
SANGER |
BT-549 |
Growth inhibition assay |
|
|
|
Inhibition of human BT-549 cell growth in a cell viability assay, IC50 = 1.3617 μM. |
SANGER |
COLO-679 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-679 cell growth in a cell viability assay, IC50 = 1.3815 μM. |
SANGER |
NCI-SNU-5 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-SNU-5 cell growth in a cell viability assay, IC50 = 1.38647 μM. |
SANGER |
NB12 |
Growth inhibition assay |
|
|
|
Inhibition of human NB12 cell growth in a cell viability assay, IC50 = 1.39558 μM. |
SANGER |
NCI-H2291 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2291 cell growth in a cell viability assay, IC50 = 1.40653 μM. |
SANGER |
OVCAR-4 |
Growth inhibition assay |
|
|
|
Inhibition of human OVCAR-4 cell growth in a cell viability assay, IC50 = 1.4508 μM. |
SANGER |
MDA-MB-361 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-361 cell growth in a cell viability assay, IC50 = 1.45389 μM. |
SANGER |
GAK |
Growth inhibition assay |
|
|
|
Inhibition of human GAK cell growth in a cell viability assay, IC50 = 1.50665 μM. |
SANGER |
SAS |
Growth inhibition assay |
|
|
|
Inhibition of human SAS cell growth in a cell viability assay, IC50 = 1.54774 μM. |
SANGER |
NCI-H441 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H441 cell growth in a cell viability assay, IC50 = 1.58956 μM. |
SANGER |
KLE |
Growth inhibition assay |
|
|
|
Inhibition of human KLE cell growth in a cell viability assay, IC50 = 1.5909 μM. |
SANGER |
HuCCT1 |
Growth inhibition assay |
|
|
|
Inhibition of human HuCCT1 cell growth in a cell viability assay, IC50 = 1.59983 μM. |
SANGER |
LS-1034 |
Growth inhibition assay |
|
|
|
Inhibition of human LS-1034 cell growth in a cell viability assay, IC50 = 1.64213 μM. |
SANGER |
Saos-2 |
Growth inhibition assay |
|
|
|
Inhibition of human Saos-2 cell growth in a cell viability assay, IC50 = 1.66455 μM. |
SANGER |
NCI-H1975 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1975 cell growth in a cell viability assay, IC50 = 1.69685 μM. |
SANGER |
CFPAC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CFPAC-1 cell growth in a cell viability assay, IC50 = 1.7227 μM. |
SANGER |
LU-65 |
Growth inhibition assay |
|
|
|
Inhibition of human LU-65 cell growth in a cell viability assay, IC50 = 1.77769 μM. |
SANGER |
DoTc2-4510 |
Growth inhibition assay |
|
|
|
Inhibition of human DoTc2-4510 cell growth in a cell viability assay, IC50 = 1.77868 μM. |
SANGER |
CP50-MEL-B |
Growth inhibition assay |
|
|
|
Inhibition of human CP50-MEL-B cell growth in a cell viability assay, IC50 = 1.83992 μM. |
SANGER |
PANC-03-27 |
Growth inhibition assay |
|
|
|
Inhibition of human PANC-03-27 cell growth in a cell viability assay, IC50 = 1.84292 μM. |
SANGER |
IA-LM |
Growth inhibition assay |
|
|
|
Inhibition of human IA-LM cell growth in a cell viability assay, IC50 = 1.89734 μM. |
SANGER |
ML-2 |
Growth inhibition assay |
|
|
|
Inhibition of human ML-2 cell growth in a cell viability assay, IC50 = 1.89978 μM. |
SANGER |
ATN-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ATN-1 cell growth in a cell viability assay, IC50 = 1.90199 μM. |
SANGER |
D-502MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-502MG cell growth in a cell viability assay, IC50 = 1.91132 μM. |
SANGER |
8305C |
Growth inhibition assay |
|
|
|
Inhibition of human 8305C cell growth in a cell viability assay, IC50 = 2.03006 μM. |
SANGER |
MC-IXC |
Growth inhibition assay |
|
|
|
Inhibition of human MC-IXC cell growth in a cell viability assay, IC50 = 2.03153 μM. |
SANGER |
SW684 |
Growth inhibition assay |
|
|
|
Inhibition of human SW684 cell growth in a cell viability assay, IC50 = 2.04455 μM. |
SANGER |
LS-123 |
Growth inhibition assay |
|
|
|
Inhibition of human LS-123 cell growth in a cell viability assay, IC50 = 2.17606 μM. |
SANGER |
GCT |
Growth inhibition assay |
|
|
|
Inhibition of human GCT cell growth in a cell viability assay, IC50 = 2.30304 μM. |
SANGER |
IST-SL1 |
Growth inhibition assay |
|
|
|
Inhibition of human IST-SL1 cell growth in a cell viability assay, IC50 = 2.33042 μM. |
SANGER |
SW837 |
Growth inhibition assay |
|
|
|
Inhibition of human SW837 cell growth in a cell viability assay, IC50 = 2.43277 μM. |
SANGER |
COR-L88 |
Growth inhibition assay |
|
|
|
Inhibition of human COR-L88 cell growth in a cell viability assay, IC50 = 2.46133 μM. |
SANGER |
HCC1954 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1954 cell growth in a cell viability assay, IC50 = 2.53005 μM. |
SANGER |
U-87-MG |
Growth inhibition assay |
|
|
|
Inhibition of human U-87-MG cell growth in a cell viability assay, IC50 = 2.58229 μM. |
SANGER |
UACC-62 |
Growth inhibition assay |
|
|
|
Inhibition of human UACC-62 cell growth in a cell viability assay, IC50 = 2.62026 μM. |
SANGER |
HuP-T4 |
Growth inhibition assay |
|
|
|
Inhibition of human HuP-T4 cell growth in a cell viability assay, IC50 = 2.68282 μM. |
SANGER |
U031 |
Growth inhibition assay |
|
|
|
Inhibition of human U031 cell growth in a cell viability assay, IC50 = 2.70111 μM. |
SANGER |
NCI-H2087 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2087 cell growth in a cell viability assay, IC50 = 2.71769 μM. |
SANGER |
HCC1395 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1395 cell growth in a cell viability assay, IC50 = 2.77564 μM. |
SANGER |
NCI-H650 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H650 cell growth in a cell viability assay, IC50 = 2.83212 μM. |
SANGER |
HT-1197 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-1197 cell growth in a cell viability assay, IC50 = 2.85285 μM. |
SANGER |
COR-L23 |
Growth inhibition assay |
|
|
|
Inhibition of human COR-L23 cell growth in a cell viability assay, IC50 = 2.91652 μM. |
SANGER |
ALL-PO |
Growth inhibition assay |
|
|
|
Inhibition of human ALL-PO cell growth in a cell viability assay, IC50 = 2.92007 μM. |
SANGER |
KYSE-150 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-150 cell growth in a cell viability assay, IC50 = 2.93449 μM. |
SANGER |
NB6 |
Growth inhibition assay |
|
|
|
Inhibition of human NB6 cell growth in a cell viability assay, IC50 = 2.94381 μM. |
SANGER |
NCI-H1395 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1395 cell growth in a cell viability assay, IC50 = 2.96085 μM. |
SANGER |
RH-18 |
Growth inhibition assay |
|
|
|
Inhibition of human RH-18 cell growth in a cell viability assay, IC50 = 3.00634 μM. |
SANGER |
HCE-4 |
Growth inhibition assay |
|
|
|
Inhibition of human HCE-4 cell growth in a cell viability assay, IC50 = 3.01069 μM. |
SANGER |
NCI-H1755 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1755 cell growth in a cell viability assay, IC50 = 3.05649 μM. |
SANGER |
KURAMOCHI |
Growth inhibition assay |
|
|
|
Inhibition of human KURAMOCHI cell growth in a cell viability assay, IC50 = 3.09323 μM. |
SANGER |
YAPC |
Growth inhibition assay |
|
|
|
Inhibition of human YAPC cell growth in a cell viability assay, IC50 = 3.11291 μM. |
SANGER |
LB2518-MEL |
Growth inhibition assay |
|
|
|
Inhibition of human LB2518-MEL cell growth in a cell viability assay, IC50 = 3.17578 μM. |
SANGER |
LB373-MEL-D |
Growth inhibition assay |
|
|
|
Inhibition of human LB373-MEL-D cell growth in a cell viability assay, IC50 = 3.1894 μM. |
SANGER |
LoVo |
Growth inhibition assay |
|
|
|
Inhibition of human LoVo cell growth in a cell viability assay, IC50 = 3.25446 μM. |
SANGER |
NCI-H1048 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1048 cell growth in a cell viability assay, IC50 = 3.28063 μM. |
SANGER |
SW1573 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1573 cell growth in a cell viability assay, IC50 = 3.39065 μM. |
SANGER |
HCT-116 |
Growth inhibition assay |
|
|
|
Inhibition of human HCT-116 cell growth in a cell viability assay, IC50 = 3.41438 μM. |
SANGER |
NEC8 |
Growth inhibition assay |
|
|
|
Inhibition of human NEC8 cell growth in a cell viability assay, IC50 = 3.53767 μM. |
SANGER |
JVM-2 |
Growth inhibition assay |
|
|
|
Inhibition of human JVM-2 cell growth in a cell viability assay, IC50 = 3.5842 μM. |
SANGER |
NCI-H2347 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2347 cell growth in a cell viability assay, IC50 = 3.59686 μM. |
SANGER |
C8166 |
Growth inhibition assay |
|
|
|
Inhibition of human C8166 cell growth in a cell viability assay, IC50 = 3.59699 μM. |
SANGER |
CAS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAS-1 cell growth in a cell viability assay, IC50 = 3.61667 μM. |
SANGER |
no-11 |
Growth inhibition assay |
|
|
|
Inhibition of human no-11 cell growth in a cell viability assay, IC50 = 3.62102 μM. |
SANGER |
A704 |
Growth inhibition assay |
|
|
|
Inhibition of human A704 cell growth in a cell viability assay, IC50 = 3.68806 μM. |
SANGER |
CP66-MEL |
Growth inhibition assay |
|
|
|
Inhibition of human CP66-MEL cell growth in a cell viability assay, IC50 = 3.74023 μM. |
SANGER |
NCI-H1770 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1770 cell growth in a cell viability assay, IC50 = 3.80523 μM. |
SANGER |
BB30-HNC |
Growth inhibition assay |
|
|
|
Inhibition of human BB30-HNC cell growth in a cell viability assay, IC50 = 3.83852 μM. |
SANGER |
DMS-79 |
Growth inhibition assay |
|
|
|
Inhibition of human DMS-79 cell growth in a cell viability assay, IC50 = 3.84658 μM. |
SANGER |
DJM-1 |
Growth inhibition assay |
|
|
|
Inhibition of human DJM-1 cell growth in a cell viability assay, IC50 = 3.84886 μM. |
SANGER |
Calu-6 |
Growth inhibition assay |
|
|
|
Inhibition of human Calu-6 cell growth in a cell viability assay, IC50 = 3.8595 μM. |
SANGER |
HCC2998 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC2998 cell growth in a cell viability assay, IC50 = 3.86497 μM. |
SANGER |
NCI-H2122 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2122 cell growth in a cell viability assay, IC50 = 3.98583 μM. |
SANGER |
HCC1569 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1569 cell growth in a cell viability assay, IC50 = 4.22325 μM. |
SANGER |
SCC-9 |
Growth inhibition assay |
|
|
|
Inhibition of human SCC-9 cell growth in a cell viability assay, IC50 = 4.24321 μM. |
SANGER |
UACC-893 |
Growth inhibition assay |
|
|
|
Inhibition of human UACC-893 cell growth in a cell viability assay, IC50 = 4.24635 μM. |
SANGER |
KU812 |
Growth inhibition assay |
|
|
|
Inhibition of human KU812 cell growth in a cell viability assay, IC50 = 4.48868 μM. |
SANGER |
HOP-62 |
Growth inhibition assay |
|
|
|
Inhibition of human HOP-62 cell growth in a cell viability assay, IC50 = 4.52942 μM. |
SANGER |
CAL-85-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-85-1 cell growth in a cell viability assay, IC50 = 4.54395 μM. |
SANGER |
SHP-77 |
Growth inhibition assay |
|
|
|
Inhibition of human SHP-77 cell growth in a cell viability assay, IC50 = 4.61889 μM. |
SANGER |
NCI-H2405 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2405 cell growth in a cell viability assay, IC50 = 4.71275 μM. |
SANGER |
OVCAR-3 |
Growth inhibition assay |
|
|
|
Inhibition of human OVCAR-3 cell growth in a cell viability assay, IC50 = 4.91737 μM. |
SANGER |
HT-144 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-144 cell growth in a cell viability assay, IC50 = 4.93929 μM. |
SANGER |
FADU |
Growth inhibition assay |
|
|
|
Inhibition of human FADU cell growth in a cell viability assay, IC50 = 4.95088 μM. |
SANGER |
TGBC11TKB |
Growth inhibition assay |
|
|
|
Inhibition of human TGBC11TKB cell growth in a cell viability assay, IC50 = 5.02982 μM. |
SANGER |
NCI-H2052 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2052 cell growth in a cell viability assay, IC50 = 5.06257 μM. |
SANGER |
GP5d |
Growth inhibition assay |
|
|
|
Inhibition of human GP5d cell growth in a cell viability assay, IC50 = 5.08943 μM. |
SANGER |
KP-N-YN |
Growth inhibition assay |
|
|
|
Inhibition of human KP-N-YN cell growth in a cell viability assay, IC50 = 5.17794 μM. |
SANGER |
LS-411N |
Growth inhibition assay |
|
|
|
Inhibition of human LS-411N cell growth in a cell viability assay, IC50 = 5.41851 μM. |
SANGER |
MZ1-PC |
Growth inhibition assay |
|
|
|
Inhibition of human MZ1-PC cell growth in a cell viability assay, IC50 = 5.77734 μM. |
SANGER |
HT55 |
Growth inhibition assay |
|
|
|
Inhibition of human HT55 cell growth in a cell viability assay, IC50 = 6.07538 μM. |
SANGER |
MKN7 |
Growth inhibition assay |
|
|
|
Inhibition of human MKN7 cell growth in a cell viability assay, IC50 = 6.15543 μM. |
SANGER |
TE-9 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-9 cell growth in a cell viability assay, IC50 = 6.17025 μM. |
SANGER |
LAN-6 |
Growth inhibition assay |
|
|
|
Inhibition of human LAN-6 cell growth in a cell viability assay, IC50 = 6.31122 μM. |
SANGER |
MHH-NB-11 |
Growth inhibition assay |
|
|
|
Inhibition of human MHH-NB-11 cell growth in a cell viability assay, IC50 = 6.50631 μM. |
SANGER |
COLO-829 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-829 cell growth in a cell viability assay, IC50 = 6.51542 μM. |
SANGER |
ESS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ESS-1 cell growth in a cell viability assay, IC50 = 6.57447 μM. |
SANGER |
RCC10RGB |
Growth inhibition assay |
|
|
|
Inhibition of human RCC10RGB cell growth in a cell viability assay, IC50 = 6.73892 μM. |
SANGER |
D-283MED |
Growth inhibition assay |
|
|
|
Inhibition of human D-283MED cell growth in a cell viability assay, IC50 = 6.86372 μM. |
SANGER |
C3A |
Growth inhibition assay |
|
|
|
Inhibition of human C3A cell growth in a cell viability assay, IC50 = 7.03211 μM. |
SANGER |
COLO-678 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-678 cell growth in a cell viability assay, IC50 = 7.13662 μM. |
SANGER |
OAW-28 |
Growth inhibition assay |
|
|
|
Inhibition of human OAW-28 cell growth in a cell viability assay, IC50 = 7.19267 μM. |
SANGER |
A388 |
Growth inhibition assay |
|
|
|
Inhibition of human A388 cell growth in a cell viability assay, IC50 = 7.61434 μM. |
SANGER |
G-402 |
Growth inhibition assay |
|
|
|
Inhibition of human G-402 cell growth in a cell viability assay, IC50 = 7.81597 μM. |
SANGER |
NB17 |
Growth inhibition assay |
|
|
|
Inhibition of human NB17 cell growth in a cell viability assay, IC50 = 8.26304 μM. |
SANGER |
COLO-668 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-668 cell growth in a cell viability assay, IC50 = 8.4187 μM. |
SANGER |
MFH-ino |
Growth inhibition assay |
|
|
|
Inhibition of human MFH-ino cell growth in a cell viability assay, IC50 = 8.58367 μM. |
SANGER |
LS-513 |
Growth inhibition assay |
|
|
|
Inhibition of human LS-513 cell growth in a cell viability assay, IC50 = 8.59 μM. |
SANGER |
MOLT-13 |
Growth inhibition assay |
|
|
|
Inhibition of human MOLT-13 cell growth in a cell viability assay, IC50 = 8.59511 μM. |
SANGER |
SW872 |
Growth inhibition assay |
|
|
|
Inhibition of human SW872 cell growth in a cell viability assay, IC50 = 8.91481 μM. |
SANGER |
RCM-1 |
Growth inhibition assay |
|
|
|
Inhibition of human RCM-1 cell growth in a cell viability assay, IC50 = 9.09658 μM. |
SANGER |
SW1116 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1116 cell growth in a cell viability assay, IC50 = 9.10722 μM. |
SANGER |
NCI-H69 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H69 cell growth in a cell viability assay, IC50 = 9.61206 μM. |
SANGER |
Capan-2 |
Growth inhibition assay |
|
|
|
Inhibition of human Capan-2 cell growth in a cell viability assay, IC50 = 10.0202 μM. |
SANGER |
SW948 |
Growth inhibition assay |
|
|
|
Inhibition of human SW948 cell growth in a cell viability assay, IC50 = 10.4142 μM. |
SANGER |
SW1417 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1417 cell growth in a cell viability assay, IC50 = 10.794 μM. |
SANGER |
HCC1937 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1937 cell growth in a cell viability assay, IC50 = 11.322 μM. |
SANGER |
NCI-H510A |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H510A cell growth in a cell viability assay, IC50 = 11.9708 μM. |
SANGER |
MDA-MB-157 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-157 cell growth in a cell viability assay, IC50 = 13.9409 μM. |
SANGER |
T84 |
Growth inhibition assay |
|
|
|
Inhibition of human T84 cell growth in a cell viability assay, IC50 = 14.3826 μM. |
SANGER |
NCI-H2029 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2029 cell growth in a cell viability assay, IC50 = 14.4817 μM. |
SANGER |
TE-10 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-10 cell growth in a cell viability assay, IC50 = 14.494 μM. |
SANGER |
NCI-H1993 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1993 cell growth in a cell viability assay, IC50 = 15.3309 μM. |
SANGER |
NCI-H630 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H630 cell growth in a cell viability assay, IC50 = 15.6115 μM. |
SANGER |
HCT-15 |
Growth inhibition assay |
|
|
|
Inhibition of human HCT-15 cell growth in a cell viability assay, IC50 = 15.9411 μM. |
SANGER |
no-10 |
Growth inhibition assay |
|
|
|
Inhibition of human no-10 cell growth in a cell viability assay, IC50 = 16.1357 μM. |
SANGER |
K-562 |
Growth inhibition assay |
|
|
|
Inhibition of human K-562 cell growth in a cell viability assay, IC50 = 16.7384 μM. |
SANGER |
COLO-824 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-824 cell growth in a cell viability assay, IC50 = 18.1783 μM. |
SANGER |
COLO-320-HSR |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-320-HSR cell growth in a cell viability assay, IC50 = 18.3911 μM. |
SANGER |
CCRF-CEM |
Growth inhibition assay |
|
|
|
Inhibition of human CCRF-CEM cell growth in a cell viability assay, IC50 = 18.5294 μM. |
SANGER |
NCI-H2009 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2009 cell growth in a cell viability assay, IC50 = 18.7815 μM. |
SANGER |
HT-29 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-29 cell growth in a cell viability assay, IC50 = 18.8874 μM. |
SANGER |
CW-2 |
Growth inhibition assay |
|
|
|
Inhibition of human CW-2 cell growth in a cell viability assay, IC50 = 21.4137 μM. |
SANGER |
HCC1187 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1187 cell growth in a cell viability assay, IC50 = 24.6168 μM. |
SANGER |
SK-LMS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-LMS-1 cell growth in a cell viability assay, IC50 = 27.4476 μM. |
SANGER |
SJRH30 |
Growth inhibition assay |
|
|
|
Inhibition of human SJRH30 cell growth in a cell viability assay, IC50 = 36.6109 μM. |
SANGER |
HUTU-80 |
Growth inhibition assay |
|
|
|
Inhibition of human HUTU-80 cell growth in a cell viability assay, IC50 = 43.7905 μM. |
SANGER |